elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38430335-58993667-45A6-423A-B3AE-B4D7368B2C2A
Q38430335-58993667-45A6-423A-B3AE-B4D7368B2C2A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38430335-58993667-45A6-423A-B3AE-B4D7368B2C2A
A phase I study of cabozantinib (XL184) in patients with renal cell cancer.
P2860
Q38430335-58993667-45A6-423A-B3AE-B4D7368B2C2A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38430335-58993667-45A6-423A-B3AE-B4D7368B2C2A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a742793731ff159d8eb9274f3516738b313f88e4
P2860
MET and VEGF: synergistic targets in castration-resistant prostate cancer